Hedge Funds Are Buying Endocyte, Inc. (ECYT)

Page 2 of 2

With the returns exhibited by our time-tested strategies, retail investors must always keep an eye on hedge fund and insider trading sentiment, and Endocyte, Inc. (NASDAQ:ECYT) is no exception.

Click here to learn why you should track hedge funds

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) 9 0 1
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) 17 0 0
Keryx Biopharmaceuticals (NASDAQ:KERX) 17 0 2
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) 16 0 3
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 10 0 4
Page 2 of 2